- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-2-2-1-1-1-1-1-1-1-1-2-mer
- Ligands
- 5 x MQ9: MENAQUINONE-9(Non-covalent)
- 2 x WUO: acyl-phosphatidyl-myo-inositol dimannoside (AcPIM2)(Non-covalent)
WUO.2: 21 residues within 4Å:- Chain A: K.181, D.193, G.195, A.237, P.240, S.241, G.244, Y.245, G.246, M.257, I.261, I.262
- Chain C: L.274, L.278
- Chain F: P.111, W.112, L.113, A.115, A.116, F.120
- Ligands: CDL.11
19 PLIP interactions:12 interactions with chain A, 5 interactions with chain F, 2 interactions with chain C- Hydrophobic interactions: A:Y.245, A:M.257, A:I.262, F:W.112, F:W.112, F:L.113, F:A.115, F:A.116, C:L.274, C:L.278
- Hydrogen bonds: A:D.193, A:D.193, A:A.237, A:S.241, A:Y.245, A:G.246, A:G.248
- Water bridges: A:G.248
- Salt bridges: A:K.181
WUO.18: 22 residues within 4Å:- Chain D: V.68, G.69, H.70, V.71, W.74, F.75, G.78, F.79, A.85, L.86
- Chain G: L.57, F.61, F.73
- Chain H: L.335
- Chain K: G.27, Q.28, I.29
- Ligands: CDL.17, HEA.25, CDL.27, 9XX.31, 9YF.36
15 PLIP interactions:9 interactions with chain D, 2 interactions with chain K, 1 interactions with chain H, 3 interactions with chain G- Hydrophobic interactions: D:W.74, D:W.74, D:F.75, D:F.75, D:F.79, D:A.85, D:L.86, G:L.57, G:F.61
- Hydrogen bonds: D:H.70, D:V.71, K:Q.28, K:I.29, H:L.335, G:F.73
- 2 x HEC: HEME C(Covalent)
HEC.3: 25 residues within 4Å:- Chain A: F.99, R.105, Q.114, A.115, N.171, C.172, C.175, H.176, L.185, Y.190, A.191, P.192, L.194, A.197, I.202, A.205, M.206, P.210, Q.211, N.212, M.213, P.214, F.216, I.229
- Chain B: Y.343
22 PLIP interactions:22 interactions with chain A,- Hydrophobic interactions: A:F.99, A:L.185, A:A.191, A:P.192, A:L.194, A:L.194, A:A.197, A:I.202, A:I.202, A:A.205, A:P.210, A:M.213, A:F.216, A:I.229
- Hydrogen bonds: A:Q.100
- Water bridges: A:R.105, A:Q.114, A:A.197, A:A.197
- Salt bridges: A:R.105, A:R.105
- Metal complexes: A:H.176
HEC.4: 22 residues within 4Å:- Chain A: S.70, C.71, C.74, H.75, R.85, P.87, L.89, T.92, A.96, V.97, Q.100, M.106, P.107, A.108, A.115, F.122, Q.211
- Chain H: W.138
- Chain K: T.32, Q.35, P.37, A.38
13 PLIP interactions:11 interactions with chain A, 1 interactions with chain H, 1 interactions with chain K,- Hydrophobic interactions: A:P.87, A:L.89, A:L.89, A:V.97, A:Q.100, A:P.107, A:F.122, H:W.138
- Hydrogen bonds: A:Q.100, A:Q.211, K:A.38
- Water bridges: A:Q.211
- Metal complexes: A:H.75
- 2 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
FES.6: 8 residues within 4Å:- Chain B: C.333, H.335, L.336, C.338, C.352, C.354, H.355, S.357
4 PLIP interactions:4 interactions with chain B,- Metal complexes: B:C.333, B:H.335, B:C.352, B:H.355
FES.47: 8 residues within 4Å:- Chain N: C.333, H.335, L.336, C.338, C.352, C.354, H.355, S.357
4 PLIP interactions:4 interactions with chain N,- Metal complexes: N:C.333, N:H.335, N:C.352, N:H.355
- 3 x 9YF: (2R)-2-(hexadecanoyloxy)-3-{[(S)-hydroxy{[(1R,2R,3R,4R,5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propyl (9S)-9-methyloctadecanoate(Non-covalent)
9YF.7: 16 residues within 4Å:- Chain B: V.200, I.203, G.204, G.205, I.207, K.208, N.209, K.212
- Chain C: I.185, W.188, M.189
- Chain M: E.98, R.100
- Chain N: L.95, F.96, W.99
15 PLIP interactions:2 interactions with chain M, 8 interactions with chain B, 2 interactions with chain N, 3 interactions with chain C- Hydrogen bonds: M:R.100, B:K.208, B:K.208, B:N.209
- Salt bridges: M:R.100, B:K.212
- Hydrophobic interactions: B:V.200, B:I.203, B:I.207, B:I.207, N:L.95, N:F.96, C:I.185, C:W.188, C:W.188
9YF.36: 24 residues within 4Å:- Chain A: S.187
- Chain C: L.386, S.403, N.405, A.406, W.409, I.410, I.413, G.414, L.418
- Chain D: V.71, E.72, F.75, F.79
- Chain G: I.141
- Chain K: C.24, S.25, I.29, Q.31
- Ligands: MQ9.5, CDL.11, CDL.12, WUO.18, 9XX.31
19 PLIP interactions:10 interactions with chain C, 1 interactions with chain A, 1 interactions with chain G, 6 interactions with chain D, 1 interactions with chain K- Hydrophobic interactions: C:L.386, C:W.409, C:I.410, C:I.410, C:I.410, C:I.413, C:I.413, C:L.418, G:I.141, D:F.75, D:F.75, D:F.75, D:F.75, D:F.79, D:F.79
- Hydrogen bonds: C:S.403, C:N.405, A:S.187, K:S.25
9YF.48: 13 residues within 4Å:- Chain B: L.95, W.99
- Chain C: E.98, R.100
- Chain M: I.185, W.188
- Chain N: V.200, G.204, G.205, I.207, K.208, N.209, K.212
17 PLIP interactions:9 interactions with chain N, 2 interactions with chain C, 4 interactions with chain M, 2 interactions with chain B- Hydrophobic interactions: N:V.200, N:V.200, N:I.207, N:I.207, M:I.185, M:I.185, M:W.188, M:W.188, B:L.95
- Hydrogen bonds: N:K.208, N:N.209, N:K.212, N:K.212, C:R.100, B:W.99
- Salt bridges: N:K.212, C:R.100
- 4 x 7PH: (1R)-2-(dodecanoyloxy)-1-[(phosphonooxy)methyl]ethyl tetradecanoate(Non-covalent)
7PH.8: 12 residues within 4Å:- Chain B: L.168, T.169, L.172, E.173, S.175, L.177, L.187
- Chain M: A.6, M.254, V.259
- Chain N: F.137, I.142
10 PLIP interactions:5 interactions with chain B, 3 interactions with chain N, 2 interactions with chain M- Hydrophobic interactions: B:L.172, B:L.172, B:L.187, N:F.137, N:F.137, N:I.142, M:A.6, M:V.259
- Hydrogen bonds: B:T.169
- Salt bridges: B:K.178
7PH.19: 11 residues within 4Å:- Chain C: F.502
- Chain E: F.107, V.156, V.159, L.162, A.163, K.166, M.167
- Chain F: I.122, W.134
- Ligands: CDL.16
9 PLIP interactions:1 interactions with chain C, 6 interactions with chain E, 2 interactions with chain F- Hydrophobic interactions: C:F.502, E:F.107, E:F.107, E:V.156, E:V.159, E:L.162, E:A.163, F:I.122
- Salt bridges: F:K.138
7PH.50: 13 residues within 4Å:- Chain C: A.9, A.10, G.13, D.14, I.16, D.17, S.23, M.254
- Chain N: R.161, K.162, V.164, A.165
- Ligands: CDL.40
6 PLIP interactions:3 interactions with chain N, 3 interactions with chain C- Hydrophobic interactions: N:V.164, C:A.9, C:I.16, C:D.17
- Salt bridges: N:R.161, N:K.162
7PH.51: 11 residues within 4Å:- Chain B: F.137
- Chain C: F.5, A.6, M.254, V.259
- Chain N: L.168, T.169, L.172, L.177, K.178
- Ligands: MQ9.15
9 PLIP interactions:2 interactions with chain B, 6 interactions with chain N, 1 interactions with chain C- Hydrophobic interactions: B:F.137, B:F.137, N:L.168, N:L.172, N:L.172, N:L.172, C:V.259
- Salt bridges: N:K.178, N:K.178
- 2 x IZL: [(2~{R})-3-[[(1~{S},2~{R},3~{S},4~{S},5~{R},6~{R})-2-[(2~{R},3~{S},4~{S},5~{S},6~{R})-6-[[(2~{S},3~{S},4~{S},5~{S},6~{R})-6-[[(2~{S},3~{S},4~{S},5~{S},6~{R})-6-(hydroxymethyl)-3-[(2~{R},3~{S},4~{S},5~{S},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-4,5-bis(oxidanyl)oxan-2-yl]oxymethyl]-3,4,5-tris(oxidanyl)oxan-2-yl]oxymethyl]-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-3,4,5-tris(oxidanyl)-6-[(2~{R},3~{S},4~{S},5~{S},6~{R})-3,4,5-tris(oxidanyl)-6-(undecanoyloxymethyl)oxan-2-yl]oxy-cyclohexyl]oxy-oxidanyl-phosphoryl]oxy-2-undecanoyloxy-propyl] (10~{R})-10-methyldodecanoate(Non-covalent)
IZL.9: 14 residues within 4Å:- Chain B: W.211, K.222, A.223, W.226, W.404, E.405, R.406, K.407
- Chain C: V.184, I.185, T.187, W.188, G.324, H.325
14 PLIP interactions:4 interactions with chain C, 10 interactions with chain B- Hydrophobic interactions: C:V.184, C:W.188
- Hydrogen bonds: C:T.187, B:W.211, B:K.222, B:K.222, B:W.226, B:E.405, B:E.405, B:R.406, B:K.407
- Salt bridges: C:H.325
- Water bridges: B:N.209, B:N.209
IZL.49: 11 residues within 4Å:- Chain M: V.184, W.188, G.324, H.325
- Chain N: W.211, K.222, W.226, W.404, E.405, R.406, K.407
9 PLIP interactions:8 interactions with chain N, 1 interactions with chain M- Hydrogen bonds: N:W.211, N:W.211, N:K.222, N:K.222, N:W.226, N:E.405, N:E.405, N:K.407
- Salt bridges: M:H.325
- 4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
HEM.10: 22 residues within 4Å:- Chain C: F.50, L.53, L.54, G.57, V.58, L.60, T.61, F.64, R.106, H.109, H.110, A.113, F.116, E.154, G.158, Y.159, L.161, P.162, Y.208, H.211, N.282
- Chain M: L.213
21 PLIP interactions:20 interactions with chain C, 1 interactions with chain M,- Hydrophobic interactions: C:F.50, C:L.53, C:L.53, C:L.54, C:L.60, C:F.64, C:H.110, C:F.116, C:E.154, C:Y.159, C:L.161, C:Y.208, M:L.213
- Hydrogen bonds: C:R.106, C:N.282
- Salt bridges: C:R.106, C:H.110
- pi-Stacking: C:H.109, C:H.211
- Metal complexes: C:H.109, C:H.211
HEM.14: 24 residues within 4Å:- Chain C: F.40, G.43, E.44, A.46, L.47, F.116, I.120, H.123, L.124, R.126, I.127, A.132, R.137, N.140, W.141, G.144, S.145, L.147, I.223, H.226, V.230, H.235, T.236
- Ligands: MQ9.15
21 PLIP interactions:21 interactions with chain C,- Hydrophobic interactions: C:A.46, C:F.116, C:I.120, C:I.120, C:I.127, C:I.127, C:W.141, C:L.147, C:I.223
- Hydrogen bonds: C:G.43, C:R.137, C:T.236
- Water bridges: C:L.42, C:L.42
- Salt bridges: C:H.123, C:R.126, C:R.126, C:H.235, C:H.235
- Metal complexes: C:H.123, C:H.226
HEM.41: 24 residues within 4Å:- Chain M: F.50, L.53, L.54, G.57, V.58, L.60, T.61, F.64, R.106, H.109, H.110, A.113, E.154, G.155, G.158, Y.159, L.161, P.162, Y.208, H.211, I.212, P.216, N.282, Y.304
18 PLIP interactions:18 interactions with chain M,- Hydrophobic interactions: M:F.50, M:L.53, M:L.53, M:L.54, M:L.60, M:F.64, M:E.154, M:L.161, M:Y.208, M:I.212, M:I.212, M:P.216
- Hydrogen bonds: M:N.282
- Salt bridges: M:R.106, M:R.106, M:H.110
- Metal complexes: M:H.109, M:H.211
HEM.44: 22 residues within 4Å:- Chain M: F.40, G.43, E.44, A.46, L.47, F.116, I.120, H.123, L.124, R.126, I.127, A.132, R.137, W.141, G.144, S.145, L.147, H.226, V.230, H.235, T.236
- Ligands: MQ9.45
21 PLIP interactions:21 interactions with chain M,- Hydrophobic interactions: M:A.46, M:F.116, M:I.120, M:I.120, M:I.120, M:I.127, M:I.127, M:I.127, M:A.132, M:W.141, M:L.147
- Hydrogen bonds: M:G.43, M:E.44, M:T.236
- Salt bridges: M:H.123, M:R.126, M:R.126, M:R.137, M:H.235, M:H.235
- Metal complexes: M:H.226
- 9 x CDL: CARDIOLIPIN(Non-covalent)
CDL.11: 29 residues within 4Å:- Chain A: I.268, M.272, R.277, A.278
- Chain C: H.37, W.38, L.42, V.122, A.125, R.126, F.129, R.366, P.367, R.368, T.374, S.378, I.381, L.385, V.425, A.426, W.429, A.430, L.433, P.483
- Ligands: MQ9.1, WUO.2, CDL.12, 9XX.31, 9YF.36
20 PLIP interactions:17 interactions with chain C, 3 interactions with chain A- Hydrophobic interactions: C:W.38, C:L.42, C:V.122, C:A.125, C:F.129, C:F.129, C:F.129, C:I.381, C:A.426, C:W.429, C:L.433, A:I.268, A:I.268
- Hydrogen bonds: C:R.366, C:R.366, C:R.368, A:A.278
- Salt bridges: C:H.37, C:R.366, C:R.368
CDL.12: 18 residues within 4Å:- Chain C: R.368, W.429, L.433, L.484, K.486, R.487
- Chain F: W.90, S.98, T.101, F.120, S.124
- Chain G: Y.29, I.32, F.131
- Ligands: MQ9.5, CDL.11, CDL.16, 9YF.36
17 PLIP interactions:13 interactions with chain C, 2 interactions with chain G, 1 interactions with chain A, 1 interactions with chain F- Hydrophobic interactions: C:W.429, G:F.131, F:F.120
- Hydrogen bonds: C:L.484, C:L.484, C:K.486, G:Y.29
- Water bridges: C:R.366, C:R.366, C:R.366, C:R.368, C:R.368, C:R.487
- Salt bridges: C:R.368, C:K.486, C:R.487, A:R.277
CDL.16: 21 residues within 4Å:- Chain A: I.261, V.265, A.266, I.268, G.269, M.272, W.273, R.277
- Chain B: K.139
- Chain C: R.487, K.490
- Chain F: W.91, A.119, I.122, T.123, C.126, W.134, G.135, E.137
- Ligands: CDL.12, 7PH.19
15 PLIP interactions:4 interactions with chain C, 4 interactions with chain F, 6 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: C:K.490, C:K.490
- Salt bridges: C:R.487, C:K.490, A:R.277, B:K.139
- Hydrophobic interactions: F:W.91, F:A.119, F:I.122, F:T.123, A:I.261, A:V.265, A:A.266, A:I.268, A:W.273
CDL.17: 26 residues within 4Å:- Chain C: M.379, A.420, Y.423, F.424, R.428
- Chain D: I.45, M.48, H.49, G.51, G.52, V.87, R.89, N.90, L.93, R.94, I.99
- Chain G: M.21, K.24, L.27, V.46, W.493, F.496, K.497, R.500
- Ligands: WUO.18, CDL.27
18 PLIP interactions:5 interactions with chain D, 7 interactions with chain G, 6 interactions with chain C- Hydrophobic interactions: D:V.87, G:L.27, G:V.46, G:W.493, G:W.493, G:F.496, G:F.496, C:A.420, C:Y.423, C:Y.423, C:F.424
- Hydrogen bonds: D:N.90, C:R.428
- Salt bridges: D:R.89, D:R.89, D:R.94, G:K.24, C:R.428
CDL.23: 19 residues within 4Å:- Chain E: M.24, V.25, G.28, T.29, W.32, L.161, R.164, A.177, V.180, V.181, Y.184
- Chain F: F.99, V.125, L.128, V.129
- Chain G: F.118, P.119, R.120, L.121
17 PLIP interactions:5 interactions with chain G, 9 interactions with chain E, 3 interactions with chain F- Hydrophobic interactions: G:F.118, G:L.121, E:W.32, E:W.32, E:V.180, E:Y.184, E:Y.184, F:V.125, F:V.125, F:V.129
- Hydrogen bonds: G:R.120, G:L.121
- Salt bridges: G:R.120, E:R.164, E:R.164
- Water bridges: E:R.164, E:R.164
CDL.27: 22 residues within 4Å:- Chain C: F.424, V.425, R.428
- Chain G: M.21, G.22, P.23, K.24, G.25, N.26, L.27, I.28, I.42, M.43, V.47, F.126, W.127, V.495, W.499, R.500
- Ligands: CDL.17, WUO.18, 9XX.31
17 PLIP interactions:14 interactions with chain G, 3 interactions with chain C- Hydrophobic interactions: G:L.27, G:I.28, G:I.42, G:V.47, G:F.126, G:W.127, G:V.495, G:W.499, C:F.424, C:V.425
- Hydrogen bonds: G:G.22, G:G.25, G:N.26, G:L.27, G:I.28
- Salt bridges: G:R.500, C:R.428
CDL.40: 18 residues within 4Å:- Chain C: Y.20, P.22, A.25, R.28, Q.29, A.221, G.224, A.225, A.228, L.229, W.231, F.232
- Chain M: Y.20, H.21, P.22, R.28
- Ligands: CDL.42, 7PH.50
11 PLIP interactions:8 interactions with chain C, 3 interactions with chain M- Hydrophobic interactions: C:P.22, C:P.22, C:A.25, C:Q.29, C:L.229, C:F.232
- Hydrogen bonds: C:Q.29, M:R.28
- Salt bridges: C:R.28, M:H.21
- Water bridges: M:R.28
CDL.42: 18 residues within 4Å:- Chain C: Y.20, H.21, R.28, I.143
- Chain M: Y.20, A.25, R.28, Q.29, L.220, A.221, I.223, G.224, A.225, L.227, A.228, L.229, F.232
- Ligands: CDL.40
14 PLIP interactions:11 interactions with chain M, 3 interactions with chain C- Hydrophobic interactions: M:Y.20, M:L.220, M:I.223, M:A.225, M:L.227, M:L.227, M:A.228, M:L.229, M:F.232, M:F.232, C:I.143
- Salt bridges: M:R.28, C:H.21
- Hydrogen bonds: C:R.28
CDL.43: 18 residues within 4Å:- Chain M: H.37, W.38, M.121, A.125, F.129, T.130, F.238, R.366, P.367, R.368, T.374, S.378, I.381, A.382, V.425, A.426, W.429, L.433
12 PLIP interactions:12 interactions with chain M- Hydrophobic interactions: M:F.129, M:F.129, M:T.130, M:I.381, M:A.382, M:V.425, M:A.426, M:L.433
- Hydrogen bonds: M:R.368
- Salt bridges: M:H.37, M:H.37, M:R.368
- 1 x 01: Lansoprazole sulfide
01.13: 14 residues within 4Å:- Chain B: H.355
- Chain C: F.156, G.170, A.173, A.174, I.178, T.179, S.299, P.301, T.308, D.309, I.312, A.334, M.337
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:A.173, C:I.178
- Hydrogen bonds: C:D.309
- 5 x TRD: TRIDECANE(Non-covalent)
TRD.20: 4 residues within 4Å:- Chain E: F.48, R.51, T.198, V.202
2 PLIP interactions:2 interactions with chain E- Hydrophobic interactions: E:F.48, E:V.202
TRD.22: 5 residues within 4Å:- Chain E: F.44, F.48
- Chain F: V.34, W.36, T.39
6 PLIP interactions:4 interactions with chain F, 2 interactions with chain E- Hydrophobic interactions: F:V.34, F:W.36, F:W.36, F:T.39, E:F.44, E:F.48
TRD.29: 2 residues within 4Å:- Chain G: T.444, L.447
No protein-ligand interaction detected (PLIP)TRD.30: 6 residues within 4Å:- Chain G: L.371, S.375, L.447, H.450, W.451
- Chain H: L.33
5 PLIP interactions:5 interactions with chain G- Hydrophobic interactions: G:L.371, G:L.447, G:L.447, G:H.450, G:W.451
TRD.35: 2 residues within 4Å:- Chain G: W.451
- Chain H: A.30
2 PLIP interactions:2 interactions with chain G- Hydrophobic interactions: G:W.451, G:W.451
- 1 x 3PE: 1,2-Distearoyl-sn-glycerophosphoethanolamine(Non-covalent)
- 2 x HEA: HEME-A(Non-covalent)
HEA.24: 30 residues within 4Å:- Chain G: W.151, T.152, W.260, V.267, Y.268, H.313, H.314, T.330, I.333, A.334, T.337, G.338, L.370, G.373, G.376, V.377, L.379, A.380, D.385, T.389, V.394, H.397, F.398, V.401, L.402, T.405, R.459
- Chain H: V.60, I.106
- Ligands: CU.26
26 PLIP interactions:2 interactions with chain H, 24 interactions with chain G,- Hydrophobic interactions: H:V.60, H:I.106, G:W.151, G:W.260, G:V.267, G:T.330, G:A.334, G:T.337, G:L.370, G:V.377, G:L.379, G:F.398, G:F.398, G:V.401, G:V.401, G:L.402
- Hydrogen bonds: G:W.151, G:Y.268, G:Y.268, G:T.389
- Water bridges: G:H.314, G:H.314
- Salt bridges: G:R.459
- pi-Cation interactions: G:H.264, G:H.397
- Metal complexes: G:H.397
HEA.25: 30 residues within 4Å:- Chain G: F.52, L.53, G.56, L.57, A.59, F.79, F.83, H.86, G.87, M.90, L.91, G.150, W.151, Y.392, I.395, F.398, H.399, L.402, F.403, I.406, V.407, F.446, Q.449, R.459, R.460, A.481, L.484, G.485, M.488
- Ligands: WUO.18
22 PLIP interactions:22 interactions with chain G,- Hydrophobic interactions: G:F.52, G:F.52, G:M.90, G:L.91, G:L.91, G:I.395, G:F.398, G:L.402, G:I.406, G:V.407, G:A.481, G:L.484
- Hydrogen bonds: G:F.83, G:W.151, G:Q.449, G:R.460
- Water bridges: G:R.459
- Salt bridges: G:R.459, G:R.460
- pi-Stacking: G:H.399
- Metal complexes: G:H.86, G:H.399
- 3 x CU: COPPER (II) ION(Non-covalent)
CU.26: 4 residues within 4Å:- Chain G: H.264, H.313, H.314
- Ligands: HEA.24
3 PLIP interactions:3 interactions with chain G- Metal complexes: G:H.264, G:H.313, G:H.314
CU.33: 5 residues within 4Å:- Chain H: H.232, C.273, C.277, M.284
- Ligands: CU.34
3 PLIP interactions:3 interactions with chain H- Metal complexes: H:H.232, H:C.273, H:C.277
CU.34: 5 residues within 4Å:- Chain H: C.273, E.275, C.277, H.281
- Ligands: CU.33
4 PLIP interactions:4 interactions with chain H- Metal complexes: H:C.273, H:E.275, H:C.277, H:H.281
- 1 x CA: CALCIUM ION(Non-covalent)
- 3 x 9XX: (2S)-1-(hexadecanoyloxy)propan-2-yl (10S)-10-methyloctadecanoate(Non-covalent)
9XX.31: 12 residues within 4Å:- Chain C: L.418
- Chain G: F.61, L.134, F.140, I.141
- Chain K: C.24
- Ligands: MQ9.5, CDL.11, WUO.18, CDL.27, 9YF.36, PLM.37
3 PLIP interactions:2 interactions with chain G, 1 interactions with chain C- Hydrophobic interactions: G:L.134, G:I.141, C:L.418
9XX.39: 5 residues within 4Å:- Chain C: F.320, P.322, W.332
- Chain L: C.21
- Ligands: PLM.38
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:F.320, C:F.320, C:F.320, C:F.320, C:P.322, C:W.332
9XX.53: 6 residues within 4Å:- Chain M: F.320, Y.321, P.322, I.327, W.332
- Chain O: C.21
6 PLIP interactions:6 interactions with chain M- Hydrophobic interactions: M:F.320, M:F.320, M:F.320, M:P.322, M:I.327, M:W.332
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 3 x PLM: PALMITIC ACID(Non-covalent)(Covalent)
PLM.37: 6 residues within 4Å:- Chain G: Q.78, Q.81, F.140, G.145
- Chain K: C.24
- Ligands: 9XX.31
2 PLIP interactions:2 interactions with chain G- Hydrophobic interactions: G:Q.78, G:F.140
PLM.38: 7 residues within 4Å:- Chain C: W.318, E.319, F.320
- Chain D: F.58, V.61
- Chain L: C.21
- Ligands: 9XX.39
7 PLIP interactions:5 interactions with chain C, 2 interactions with chain D- Hydrophobic interactions: C:W.318, C:W.318, C:W.318, C:F.320, D:F.58, D:V.61
- Water bridges: C:E.319
PLM.52: 5 residues within 4Å:- Chain M: W.318, E.319, F.320, W.332
- Chain O: C.21
4 PLIP interactions:4 interactions with chain M- Hydrophobic interactions: M:W.318, M:W.318, M:F.320, M:W.332
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kovalova, T. et al., Inhibition mechanism of potential antituberculosis compound lansoprazole sulfide. Proc.Natl.Acad.Sci.USA (2024)
- Release Date
- 2024-11-20
- Peptides
- Cytochrome bc1 complex cytochrome c subunit: A
Cytochrome bc1 complex cytochrome c subunit: BN
Cytochrome bc1 complex cytochrome b subunit: CM
Transmembrane protein: D
Probable cytochrome c oxidase subunit 3: E
Cytochrome c oxidase polypeptide 4: F
Cytochrome c oxidase subunit 1: G
cytochrome-c oxidase: H
Cytochrome c oxidase subunit: I
Uncharacterized protein MSMEG_4692/MSMEI_4575: J
LpqE protein: K
Superoxide dismutase [Cu-Zn]: LO - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
OB
MN
GC
NM
HD
PE
SF
TG
RH
QI
UJ
VK
WL
YO
c - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-2-2-1-1-1-1-1-1-1-1-2-mer
- Ligands
- 5 x MQ9: MENAQUINONE-9(Non-covalent)
- 2 x WUO: acyl-phosphatidyl-myo-inositol dimannoside (AcPIM2)(Non-covalent)
- 2 x HEC: HEME C(Covalent)
- 2 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
- 3 x 9YF: (2R)-2-(hexadecanoyloxy)-3-{[(S)-hydroxy{[(1R,2R,3R,4R,5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propyl (9S)-9-methyloctadecanoate(Non-covalent)
- 4 x 7PH: (1R)-2-(dodecanoyloxy)-1-[(phosphonooxy)methyl]ethyl tetradecanoate(Non-covalent)
- 2 x IZL: [(2~{R})-3-[[(1~{S},2~{R},3~{S},4~{S},5~{R},6~{R})-2-[(2~{R},3~{S},4~{S},5~{S},6~{R})-6-[[(2~{S},3~{S},4~{S},5~{S},6~{R})-6-[[(2~{S},3~{S},4~{S},5~{S},6~{R})-6-(hydroxymethyl)-3-[(2~{R},3~{S},4~{S},5~{S},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-4,5-bis(oxidanyl)oxan-2-yl]oxymethyl]-3,4,5-tris(oxidanyl)oxan-2-yl]oxymethyl]-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-3,4,5-tris(oxidanyl)-6-[(2~{R},3~{S},4~{S},5~{S},6~{R})-3,4,5-tris(oxidanyl)-6-(undecanoyloxymethyl)oxan-2-yl]oxy-cyclohexyl]oxy-oxidanyl-phosphoryl]oxy-2-undecanoyloxy-propyl] (10~{R})-10-methyldodecanoate(Non-covalent)
- 4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 9 x CDL: CARDIOLIPIN(Non-covalent)
- 1 x 01: Lansoprazole sulfide
- 5 x TRD: TRIDECANE(Non-covalent)
- 1 x 3PE: 1,2-Distearoyl-sn-glycerophosphoethanolamine(Non-covalent)
- 2 x HEA: HEME-A(Non-covalent)
- 3 x CU: COPPER (II) ION(Non-covalent)
- 1 x CA: CALCIUM ION(Non-covalent)
- 3 x 9XX: (2S)-1-(hexadecanoyloxy)propan-2-yl (10S)-10-methyloctadecanoate(Non-covalent)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 3 x PLM: PALMITIC ACID(Non-covalent)(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kovalova, T. et al., Inhibition mechanism of potential antituberculosis compound lansoprazole sulfide. Proc.Natl.Acad.Sci.USA (2024)
- Release Date
- 2024-11-20
- Peptides
- Cytochrome bc1 complex cytochrome c subunit: A
Cytochrome bc1 complex cytochrome c subunit: BN
Cytochrome bc1 complex cytochrome b subunit: CM
Transmembrane protein: D
Probable cytochrome c oxidase subunit 3: E
Cytochrome c oxidase polypeptide 4: F
Cytochrome c oxidase subunit 1: G
cytochrome-c oxidase: H
Cytochrome c oxidase subunit: I
Uncharacterized protein MSMEG_4692/MSMEI_4575: J
LpqE protein: K
Superoxide dismutase [Cu-Zn]: LO - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
OB
MN
GC
NM
HD
PE
SF
TG
RH
QI
UJ
VK
WL
YO
c - Membrane
-
We predict this structure to be a membrane protein.